We are live on ! Find out more
EI

EAM Investors Portfolio holdings

AUM $866M
1-Year Est. Return 377.14%
This Fund
S&P 500
This Quarter Est. Return
+39.39%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.07%
10 Year Est. Return
+19,957,621.5%
AUM
$460M
AUM Growth
+$50.4M
Cap. Flow
+$4.03M
Cap. Flow %
0.88%
Top 10 Hldgs %
10.23%
Holding
385
New
140
Increased
52
Reduced
54
Closed
139

Top Sells

Rank Stock Value
1
RCMT icon
RCM Technologies
RCMT
+$5.05M
2
EOLS icon
Evolus
EOLS
+$4.7M
3
VTNR
Vertex Energy, Inc
VTNR
+$3.81M
4
GOLD
Gold.com Inc
GOLD
+$3.36M
5
MTUS icon
Metallus
MTUS
+$3.34M

Sector Composition

Rank Sector Weight
1 Healthcare 33%
2 Technology 16.45%
3 Industrials 16.35%
4 Energy 7.66%
5 Financials 7.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INSW icon
26
International Seaways
INSW
$4.49B
$3.12M 0.68%
88,921
-6,364
-7% -$176K
ELF icon
27
e.l.f. Beauty
ELF
$5.09B
$3.11M 0.68%
82,788
+6,865
+9% +$248K
HURN icon
28
Huron Consulting
HURN
$2.38B
$3.09M 0.67%
46,578
+3,817
+9% +$253K
CBZ icon
29
CBIZ
CBZ
$2.97B
$3.01M 0.65%
70,348
+33,831
+93% +$1.48M
SANM icon
30
Sanmina
SANM
$10.7B
$2.96M 0.64%
64,271
+5,112
+9% +$238K
RXDX
31
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$2.95M 0.64%
+50,054
New +$2.29M
DXLG icon
32
Destination XL Group
DXLG
$30.7M
$2.94M 0.64%
+542,914
New +$2.59M
IMXI icon
33
International Money Express
IMXI
$370M
$2.94M 0.64%
129,103
-14,239
-10% -$335K
VTYX
34
DELISTED
Ventyx Biosciences
VTYX
$2.91M 0.63%
+83,238
New +$1.84M
TWNK
35
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
$2.9M 0.63%
124,570
-23,982
-16% -$544K
EVH icon
36
Evolent Health
EVH
$346M
$2.88M 0.63%
80,287
+19,615
+32% +$691K
AKRO
37
DELISTED
Akero Therapeutics
AKRO
$2.88M 0.63%
+84,607
New +$1.29M
NSSC icon
38
Napco Security Technologies
NSSC
$1.44B
$2.84M 0.62%
+97,535
New +$2.61M
SWAV
39
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$2.81M 0.61%
+10,116
New +$2.57M
GTHX
40
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$2.79M 0.61%
+223,654
New +$2.56M
PLMR icon
41
Palomar
PLMR
$3.55B
$2.78M 0.6%
+33,225
New +$2.44M
AGYS icon
42
Agilysys
AGYS
$3.12B
$2.78M 0.6%
50,225
+43,406
+637% +$2.19M
AREC icon
43
American Resources Corp
AREC
$229M
$2.76M 0.6%
+1,032,554
New +$2.53M
CTIC
44
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$2.74M 0.6%
470,576
-371,173
-44% -$2.31M
ISEE
45
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$2.72M 0.59%
+151,693
New +$1.99M
EXTR icon
46
Extreme Networks
EXTR
$3.43B
$2.72M 0.59%
+207,793
New +$2.62M
GFF icon
47
Griffon
GFF
$4.72B
$2.7M 0.59%
91,590
+7,362
+9% +$224K
HROW icon
48
Harrow
HROW
$1.47B
$2.7M 0.59%
+224,046
New +$1.82M
XMTR icon
49
Xometry
XMTR
$5.1B
$2.69M 0.58%
+47,311
New +$2.21M
HDSN
50
Hudson Technologies
HDSN
$262M
$2.69M 0.58%
365,337
-372,256
-50% -$3.13M

Similar funds

EAM Investors's Q3 2022 Portfolio in Review

As of Q3 2022, EAM Investors held 385 positions worth $460M, up 12% from $410M the previous quarter. Its ten largest holdings account for 10% of the portfolio.

EAM Investors's Q3 2022 filing shows 140 new, 52 increased, 54 reduced and 139 closed positions. Its largest new stake was Aehr Test Systems: 309,640 shares worth $4.37M. The largest sale was RCM Technologies, an estimated $5.05M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 23% a quarter earlier, followed by Technology and Industrials.

  • EAM Investors's largest Q3 2022 buy was Aehr Test Systems: 309,640 shares worth $4.37M.
  • EAM Investors added most to Agilysys in Q3 2022, an estimated $2.19M increase.
  • EAM Investors's biggest Q3 2022 reduction was Hudson Technologies, cutting an estimated $3.13M.
  • EAM Investors fully exited RCM Technologies in Q3 2022, selling an estimated $5.05M.
  • EAM Investors's ten largest holdings make up 10% of its $460M portfolio in Q3 2022.
  • EAM Investors opened 140 new positions and closed 139 in Q3 2022.
  • EAM Investors's portfolio value rose 12% quarter-over-quarter to $460M.

Based on EAM Investors's 13F filing for Q3 2022, filed 14 Nov 2022.